Decreasing sensitivity to cytotoxic agents parallels increasing tumorigenicity in human fibroblasts.
AffiliationPaterson Institute for Cancer Research, Christie Hospital and Holt Radium Institute, Manchester, United Kingdom.
MetadataShow full item record
AbstractHuman embryo fibroblasts of common genetic origin but exhibiting a range of phenotypes from normal to aggressively tumorigenic have been used to study resistance to the cytotoxic drugs methotrexate and N-(phosphonacetyl)-L-aspartate. Measurement of the intrinsic sensitivities of these cells to the two drugs in standard survival assays, in normal fetal bovine serum, showed increasing resistance to parallel increasing tumor-igenicity. Tumor cells were totally resistant to 10 mM N-(phosphonacetyl)-L-aspartate whereas the 50% lethal dose for methotrexate for the tumor cells was 500 nM compared with 50 nM for the normal diploid parent cell line. The difference in resistance between the immortal and tumorigenic cell lines was eliminated for both methotrexate and N-(phosphonacetyl)-L-aspartate, when the experiments were repeated in the presence of dialyzed fetal bovine serum, but could be restored by the addition of either hypoxanthine (100 microM) or uridine (10 microM). This suggested an important role for the salvage pathways of purine and pyrimidine biosynthesis in the increased resistance of the more tumorigenic cell lines. The implications of these data in relation to cancer chemotherapy will be discussed.
CitationDecreasing sensitivity to cytotoxic agents parallels increasing tumorigenicity in human fibroblasts. 1991, 51 (7):1855-9 Cancer Res.
- The propensity for gene amplification: a comparison of protocols, cell lines, and selection agents.
- Authors: Sharma RC, Schimke RT
- Issue date: 1994 Jan 16
- Effect of tumor promoter 12-O-tetradecanoylphorbol-13-acetate on recovery of methotrexate-, N-(phosphonacetyl)-L-aspartate-, and cadmium-resistant colony-forming mouse and hamster cells.
- Authors: Bojan F, Kinsella AR, Fox M
- Issue date: 1983 Nov
- Influence of both salvage and DNA damage response pathways on resistance to chemotherapeutic antimetabolites.
- Authors: Pickard M, Kinsella A
- Issue date: 1996 Aug 9
- p53 expression in normal versus transformed mammalian cells.
- Authors: Moro F, Ottaggio L, Bonatti S, Simili M, Miele M, Bozzo S, Abbondandolo A
- Issue date: 1995 Oct
- Drug resistance and gene amplification potential regulated by transforming growth factor beta 1 gene expression.
- Authors: Huang A, Jin H, Wright JA
- Issue date: 1995 Apr 15